Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$2.19 USD
+0.05 (2.10%)
Updated May 16, 2024 04:00 PM ET
Pre-Market: $2.21 +0.02 (0.91%) 9:04 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Pacific Biosciences of California (PACB) reported earnings of -$0.26 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for PACB's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 11.54%.
Earnings History
Price & Consensus
Zacks News for PACB
Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
PACB: What are Zacks experts saying now?
Zacks Private Portfolio Services